Cyr Financial Inc. Reduces Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Cyr Financial Inc. lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 69.3% during the 4th quarter, Holdings Channel reports. The firm owned 644 shares of the biotechnology company’s stock after selling 1,456 shares during the quarter. Cyr Financial Inc.’s holdings in Axon Enterprise were worth $383,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of AXON. Quent Capital LLC lifted its stake in Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares in the last quarter. Prestige Wealth Management Group LLC lifted its position in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares in the last quarter. Brooklyn Investment Group acquired a new stake in shares of Axon Enterprise during the third quarter valued at $41,000. Planning Capital Management Corp raised its stake in Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 55 shares during the last quarter. Finally, Friedenthal Financial purchased a new position in Axon Enterprise in the 3rd quarter valued at about $51,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Robert W. Baird boosted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Northland Securities boosted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Needham & Company LLC raised their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Finally, TD Cowen began coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $524.85.

Insider Buying and Selling

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the transaction, the president now owns 208,166 shares of the company’s stock, valued at $126,179,820.90. This trade represents a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 50,545 shares of company stock valued at $30,721,337. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $653.43 on Friday. The firm has a fifty day moving average of $619.32 and a 200-day moving average of $479.00. Axon Enterprise, Inc. has a 52-week low of $247.04 and a 52-week high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $49.82 billion, a P/E ratio of 168.85, a PEG ratio of 6.41 and a beta of 1.04.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.